- ACTIVE INGREDIENT
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
-
INDICATIONS & USAGE
Radiban (Potassium iodide tablet, USP) is a thyroid blocking medicine that helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency. Use along with other emergency measures recommended by public officials. Radiban is to be used only in the case of a nuclear radiation emergency. It is not for everyday use. Because of the stability of potassium iodide, the shelf life for Radiban is 10 years. -
WARNINGS
Allergy Alert: Iodine may cause an allergic reaction with one or more of the following symptoms:
- Shortness of breath or wheezing
- Swelling
- Skin rash
- Trouble breathing, speaking, or swallowing
- Fever and joint pain
- Ever had an allergic reaction to iodine
- Nodular thyroid disease with heart disease
- Hypocomplementemic vasculitis
- Dermatitis herpetiformis
Stop use and ask doctor if you have:
- Allergic reaction. Get medical help right away if you have trouble breathing, speaking, or swallowing; shortness of breath; wheezing; swelling of the mouth, tongue, or throat; or rash.
- Irregular heartbeat or chest pain. Get help right away.
- Swelling of the hands or feet, fever, or joint pain.
-
DOSAGE & ADMINISTRATION
Directions
- Use only as directed by public officials in the event of a nuclear radiation emergency.
- Do not take more than 1 dose in 24 hours.
- Tablets can be whole or crushed and mixed with milk, water, orange juice, flat soda like cola, or raspberry syrup.
Dosage:
Adults over 18 years ........................................................................... 1 tablet (whole or crushed) daily (130 mg)
Children over 12 years to 18 years who weigh at least 150 pounds .......... 1 Tablet (whole or crushed) daily (130 mg)
Children over 12 years to 18 years who weigh less than 150 pounds ....... 1/2 Tablet (whole or crushed) or 4 teaspoons of liquid mix daily (65 mg)
Children over 3 years to 12 years ........................................................ 1/2 Tablet (whole or crushed) or 4 teaspoons of liquid mix daily (65 mg)
Children over 1 month to 3 years ......................................................... 2 teaspoons of liquid mix daily (32.5 mg)
Infants at birth to 1 month ................................................................... 1 teaspoon of liquid mix daily (16.25 mg)
The liquid mixture should be given to infants, young children, and any others who cannot swallow tablets; see consumer package insert on how to make a liquid mixture.
- INACTIVE INGREDIENT
- PRINCIPAL DISPLAY PANEL
- PATIENT PACKAGE INSERT
-
INGREDIENTS AND APPEARANCE
RADIBAN
potassium iodide tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:65697-513 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Potassium Iodide (UNII: 1C4QK22F9J) (Iodine - UNII:9679TC07X4) Potassium Iodide 130 mg Inactive Ingredients Ingredient Name Strength Cellulose, Microcrystalline (UNII: OP1R32D61U) Lactose Monohydrate (UNII: EWQ57Q8I5X) Silicon Dioxide (UNII: ETJ7Z6XBU4) Magnesium Stearate (UNII: 70097M6I30) Product Characteristics Color yellow (Very light yellow - almost white tablet) Score 2 pieces Shape ROUND Size 8mm Flavor Imprint Code UT;I Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65697-513-11 10 in 1 BOX 1 NDC:65697-513-01 1 in 1 PACKET Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Export only 12/20/2011 Labeler - United Douglas Pharm., Inc. (001444350) Registrant - United Douglas Pharm., Inc. (001444350) Establishment Name Address ID/FEI Business Operations United Douglas Pharm., Inc. 001444350 pack, label Establishment Name Address ID/FEI Business Operations Korea United Pharm Inc. 688016534 manufacture